Labcorp said Tuesday that it has agreed to acquire Myriad Genetics' prenatal health testing business for $210 million. The ...

The proposed deal follows closely behind Labcorp announcing a deal to acquire certain laboratory testing businesses from ...

Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, and Waters Corporation (NYSE: WAT), a global life sciences and diagnostics leader, today announced a ...

Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, and Labcorp (NYSE: LH), a global leader in innovative and comprehensive laboratory services, ...

OPKO Health (OPK) stock jumps as Labcorp (LH) agrees to acquire a portfolio of assets held by its BioReference Health unit ...

Labcorp has agreed to acquire select BioReference Health assets from OPKO Health in a transaction that includes $722 million ...

Labcorp is outlaying up to $872m to acquire certain laboratory assets from OPKO Health subsidiary BioReference Health, ...

Labcorp acquired BioReference Health's clinical laboratory testing businesses for $722 million. Burlington-based Labcorp ...

Labcorp and OPKO Health have partnered up for an agreement that sees Labcorp acquire select assets of BioReference Health, a ...

Laboratory services provider LabCorp Holdings Inc. ( LH) announced on Tuesday that it has agreed to acquire the Prenatal Health testing business of molecular diagnostics company Myriad Genetics Inc. ( ...

HIPAA-regulated entities often need to transmit protected health information (PHI) to third parties to assist with treatment, payment and ...

Oct 15 (Reuters) - Laboratory operator Labcorp said on Thursday it will buy some assets from Opko Health's subsidiary in a ...